Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 9,005 | 4,105 | 5,163 | 4,100 |
| Marketable Securities | N/A | N/A | N/A | N/A | 3,017 |
| Receivables | N/A | 95 | 178 | 342 | 682 |
| Other current assets | 0 | 0 | 0 | 9 | 0 |
| TOTAL | $N/A | $9,114 | $4,283 | $5,514 | $7,799 |
| Non-Current Assets | |||||
| PPE Net | N/A | 388 | N/A | N/A | 68 |
| Investments And Advances | 0 | 0 | 0 | 0 | 19 |
| Other Non-Current Assets | 0 | 38 | 0 | 0 | 0 |
| TOTAL | $N/A | $426 | $N/A | $N/A | $87 |
| Total Assets | $N/A | $9,540 | $4,283 | $5,514 | $7,886 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 62 | 537 | 792 | 1,618 |
| Accrued Expenses | N/A | 634 | N/A | N/A | N/A |
| TOTAL | $N/A | $696 | $537 | $792 | $1,618 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 351 | 0 | 0 | 0 |
| TOTAL | $N/A | $351 | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $1,047 | $537 | $792 | $1,618 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 396 | 46 | 46 | 45 |
| Retained earnings | N/A | -12,047 | -45,185 | -44,114 | -42,481 |
| Other shareholders' equity | 0 | -1,503 | 0 | 0 | 0 |
| TOTAL | $N/A | $8,493 | $3,746 | $4,722 | $6,268 |
| Total Liabilities And Equity | $0 | $9,540 | $4,283 | $5,514 | $7,886 |